Infection最新文献

筛选
英文 中文
Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan. 台湾儿童接种适龄 13 价肺炎球菌结合疫苗后突破性感染的临床特征和免疫记忆。
IF 5.4 2区 医学
Infection Pub Date : 2024-11-05 DOI: 10.1007/s15010-024-02426-3
Chih-Ho Chen, Mei-Hua Hsu, Mei-Chen Ou-Yang, Chen-Ting Yin, Hsin-Chieh Li, Lin-Hui Su, Shu-Shen Cheng, Cheng-Hsun Chiu
{"title":"Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan.","authors":"Chih-Ho Chen, Mei-Hua Hsu, Mei-Chen Ou-Yang, Chen-Ting Yin, Hsin-Chieh Li, Lin-Hui Su, Shu-Shen Cheng, Cheng-Hsun Chiu","doi":"10.1007/s15010-024-02426-3","DOIUrl":"https://doi.org/10.1007/s15010-024-02426-3","url":null,"abstract":"<p><strong>Purpose: </strong>As certain vaccine serotypes are still circulating within the community during the PCV13 era, we aimed to delineate the clinical features and assess the immunity following breakthrough infections in children.</p><p><strong>Methods: </strong>101 PCVs-vaccinated children < 18 years with culture confirmed PCV13 serotype breakthrough infection (25/101, invasive pneumococcal disease [IPD]) was identified in Taiwan in 2015-2019. Immunoglobulin G (IgG) antibody levels, IgM<sup>+</sup> memory B cells (MBCs), and isotype-switched immunoglobulin (sIg<sup>+</sup>) MBC specific to serotypes 3, 14, 19 A were assessed prior to and one month after an additional PCV13 booster in 9 patients. A cohort of 89 previously vaccinated, healthy children were enrolled as controls.</p><p><strong>Results: </strong>The majority (88%) of the breakthrough infection occurred in children under 7 years old. Infection by serotypes 3 and 19 A increased in children aged 5-17 years in 2018-2019. The pre-booster serotype 3- and 19 A-specific IgG in both children with breakthrough infection and controls were lower than the IPD protective thresholds (2.83 µg/mL for 3; 1.00 µg/mL for 19 A). Breakthrough infected children showed higher geometric mean ratio in serotype-specific IgG, IgM<sup>+</sup> MBCs and sIg<sup>+</sup> MBC after an additional PCV13 booster, compared to the controls.</p><p><strong>Conclusions: </strong>Most breakthrough infections occurred in previously healthy preschool-aged children, but such infections may still occur in school-aged children due to waning immunity. Breakthrough infections may also enhance the anamnestic response elicited by PCV13.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023). 德国两个全国性艾滋病毒感染者长期队列(1999-2023 年)的艾滋病毒指标情况特征。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-30 DOI: 10.1007/s15010-024-02419-2
Amrei Krings, Christian Kollan, Daniel Schmidt, Barbara Gunsenheimer-Bartmeyer, Frederik Valbert, Anja Neumann, Jürgen Wasem, Georg M N Behrens, Markus Bickel, Christoph Boesecke, Stefan Esser, Patrik Dröge, Thomas Ruhnke, Uwe Koppe
{"title":"Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999-2023).","authors":"Amrei Krings, Christian Kollan, Daniel Schmidt, Barbara Gunsenheimer-Bartmeyer, Frederik Valbert, Anja Neumann, Jürgen Wasem, Georg M N Behrens, Markus Bickel, Christoph Boesecke, Stefan Esser, Patrik Dröge, Thomas Ruhnke, Uwe Koppe","doi":"10.1007/s15010-024-02419-2","DOIUrl":"https://doi.org/10.1007/s15010-024-02419-2","url":null,"abstract":"<p><strong>Background/objective: </strong>Information about occurrence and affected groups of symptoms/diagnoses indicative of an HIV infection (so-called HIV indicator conditions; HIV-ICs) is lacking. We analyse HIV-IC incidence, transmission risks and immune status among people living with HIV (PLWH) antiretroviral therapy (ART) naive.</p><p><strong>Methods: </strong>Diagnoses reported for ART-naive PLWH from two multicentre observational, prospective cohort studies between 1999-2023 were analysed. Incidence rates per 1,000 person-years (PYs) were calculated for the overall study period and time periods defined by ART treatment recommendations. For further description, CD4 counts around HIV-IC diagnosis (+ -30 days) and HIV-transmission routes were collected.</p><p><strong>Results: </strong>In total 15,940 diagnoses of 18,534 PLWH in Germany were included. Of those 81% were male (median age: 36 years) and 56% reported being men, who have sex with men as the likely HIV-transmission route. Incidence rates varied between the different HIV-ICs. Syphilis had the highest incidence rate (34 per 1,000 PYs; 95% confidence interval [CI] 29-40) for sexually transmitted infections (STIs), hepatitis B was highest for viral hepatitis diagnoses (18 per 1,000 PYs; 95% CI 17-20); according to CDC-classification herpes zoster for HIV-associated diagnoses (22 per 1,000; 95% CI 20-24) and candidiasis for AIDS-defining diagnoses (30 per 1,000 PYs; 95% CI 29-32). Most PLWH with HIV-ICs (hepatitis, HIV-associated diagnoses and AIDS-defining conditions) had CD4 cell counts < 350.</p><p><strong>Conclusion: </strong>This analysis characterizes HIV-ICs regarding the incidence, HIV-transmission route and patients' immune status. The results underline the importance of HIV-IC-based screening to detect PLWH with already partially impaired immune status and in need of timely ART initiation.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterizing CRP dynamics during acute infections. 描述急性感染期间 CRP 的动态特征。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-28 DOI: 10.1007/s15010-024-02422-7
Stacey S Cherny, Rafael Y Brzezinski, Asaf Wasserman, Amos Adler, Shlomo Berliner, Daniel Nevo, Saharon Rosset, Uri Obolski
{"title":"Characterizing CRP dynamics during acute infections.","authors":"Stacey S Cherny, Rafael Y Brzezinski, Asaf Wasserman, Amos Adler, Shlomo Berliner, Daniel Nevo, Saharon Rosset, Uri Obolski","doi":"10.1007/s15010-024-02422-7","DOIUrl":"https://doi.org/10.1007/s15010-024-02422-7","url":null,"abstract":"<p><strong>Purpose: </strong>C-reactive protein (CRP) is a common proxy of inflammation, but accurate characterizations of its dynamics during acute infections are scant. The goal of this study was to examine C-reactive protein (CRP) trajectories in hospitalized patients with viral infections, confirmed bacteremia (stratified by Gram-negative or Gram-positive bacteria), and non-bacteremic infections/inflammations, considering antibiotic treatment.</p><p><strong>Methods: </strong>Electronic medical records from Tel Aviv Sourasky Medical Center (July 2007-May 2023) were analyzed. Patients with blood cultures or positive viral tests were included. CRP levels were modeled using generalized additive mixed-effects models (GAMMs) and observed up to 150 h after initial infection diagnosis. Patients with initial CRP levels > 31.9 were excluded, to remove individuals already in a highly active inflammatory process. The shapes of the CRP curves were characterized and peak CRP as well as area under the CRP curve were the primary variables of interest.</p><p><strong>Results: </strong>Viral infections had the lowest and flattest CRP curves. Non-bacteremic infections showed intermediate levels, while bacteremia (especially Gram-negative under antibiotic treatment) had the highest CRP peaks. For instance, peak CRP ranged from 15.4 mg/L in viral infections without antibiotics to 140.9 mg/L in Gram-negative bacteremia with antibiotics.</p><p><strong>Conclusions: </strong>CRP trajectories significantly differ based on infection type and antibiotic treatment. Frequent CRP measurement could be a valuable diagnostic and risk stratification tool in hospitalized patients.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142521845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between adjunctive rifampin and gentamicin use and outcomes for patients with staphylococcal prosthetic valve endocarditis: a propensity-score adjusted retrospective cohort study. 葡萄球菌人工瓣膜心内膜炎患者辅助使用利福平和庆大霉素与预后之间的关系:一项倾向分数调整后的回顾性队列研究。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-23 DOI: 10.1007/s15010-024-02421-8
Hiroyuki Suzuki, Abhishek Pandya, Shinya Hasegawa, Joseph Tholany
{"title":"Association between adjunctive rifampin and gentamicin use and outcomes for patients with staphylococcal prosthetic valve endocarditis: a propensity-score adjusted retrospective cohort study.","authors":"Hiroyuki Suzuki, Abhishek Pandya, Shinya Hasegawa, Joseph Tholany","doi":"10.1007/s15010-024-02421-8","DOIUrl":"https://doi.org/10.1007/s15010-024-02421-8","url":null,"abstract":"<p><strong>Purpose: </strong>Although guidelines recommend adjunctive rifampin and gentamicin use for patients with staphylococcal prosthetic valve endocarditis (PVE), evidence behind the recommendation is limited and conflicting.</p><p><strong>Methods: </strong>We performed a retrospective cohort study of all patients with staphylococcal PVE within the Veterans Health Administration during 2003-2021. Patients were identified with diagnostic codes for prosthetic valves and positive blood cultures for Staphylococcus species and confirmed via manual chart reviews. The primary outcome was the composite of all-cause mortality or recurrence of staphylococcal PVE within one year from diagnosis. Inverse probability of treatment weighting (IPTW) was used to estimate the probability of individuals receiving rifampin using propensity scores. IPTW-adjusted multivariable Cox regression analysis was used to compare outcomes between patients who received rifampin and gentamicin, and those did not.</p><p><strong>Results: </strong>Among 373 patients with staphylococcal PVE, 275 (73.7%) and 225 (60.3%) received at least one dose of rifampin and gentamicin, respectively. The incidence of staphylococcal PVE increased from 0.47 (2003-11) to 0.77 (2012-21) per 10,000 hospitalizations. Gentamicin use declined over time (70.1% in 2003-2011 to 54.8% in 2012-2021, p = 0.04) while rifampin use did not change significantly (76.1% in 2003-2011 to 72.4% in 2012-2021, p = 0.43). The composite outcome was observed in 209 (56.0%). Neither rifampin use (adjusted hazard ratio [HR] 0.77, 95% CI 0.48-1.24) and gentamicin use (adjusted HR 1.11, 95% CI 0.71-1.74) was associated with the composite outcome.</p><p><strong>Conclusion: </strong>No significant association was observed between adjunctive rifampin or gentamicin use and improved outcomes.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal time bias and confounding. 解读庆大霉素在治疗侵袭性李斯特菌病中的作用所面临的挑战:不死时间偏差和混杂因素。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-23 DOI: 10.1007/s15010-024-02416-5
Hayato Mitaka, Takaaki Kobayashi
{"title":"Challenges in interpreting the role of gentamicin in treatment of invasive listeriosis: immortal time bias and confounding.","authors":"Hayato Mitaka, Takaaki Kobayashi","doi":"10.1007/s15010-024-02416-5","DOIUrl":"https://doi.org/10.1007/s15010-024-02416-5","url":null,"abstract":"","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrepancy between antibiotic pack sizes and guideline recommendations: a real-world analysis based on claims data. 抗生素包装规格与指南建议之间的差异:基于索赔数据的真实世界分析。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-23 DOI: 10.1007/s15010-024-02420-9
Sabrina M Stollberg, Sereina M Graber, Andreas Kronenberg, Oliver Senn, Stefan Neuner-Jehle, Catherine Pluess-Suard, Carola A Huber, Andreas Plate
{"title":"Discrepancy between antibiotic pack sizes and guideline recommendations: a real-world analysis based on claims data.","authors":"Sabrina M Stollberg, Sereina M Graber, Andreas Kronenberg, Oliver Senn, Stefan Neuner-Jehle, Catherine Pluess-Suard, Carola A Huber, Andreas Plate","doi":"10.1007/s15010-024-02420-9","DOIUrl":"https://doi.org/10.1007/s15010-024-02420-9","url":null,"abstract":"<p><strong>Purpose: </strong>Antibiotics are often only available in predefined pack sizes, which may not align with guideline recommendations. This can result in leftover pills, leading to inappropriate self-medication or waste disposal, which can both foster the development of antibiotic resistance. The magnitude of inappropriate pack sizes is largely unknown. The objective of this study was to evaluate the potential non-conformity of prescribed antibiotic pack sizes.</p><p><strong>Methods: </strong>This retrospective observational study was based on claims data from a large Swiss health insurance company. The study analysed the prescriptions of eleven different antibiotic substances recommended for the five most common indications for antibiotics in Switzerland. All prescriptions for adult outpatients issued by general practitioners in 2022 were included and extrapolated to the entire Swiss population. Potential non-conformity was defined as a mismatch between the total dosage in a pack and the total dosage recommended.</p><p><strong>Results: </strong>A total of n = 947,439 extrapolated prescriptions were analysed. In 10 of 23 of all analysed substance/indication combinations none of the prescribed packs aligned with the respective guideline recommendation. Considering pack sizes in which the total prescribed dosage of a substance did not correspond to any of the total dosages recommended in at least one of the guidelines, 31.6% of prescriptions were potentially non-conform and an estimated number of 2.7 million tablets were overprescribed.</p><p><strong>Conclusions: </strong>We found a large discrepancy between prescribed pack sizes and guideline recommendations. Since inadequately prepacked antibiotics may lead to antibiotic resistance and unnecessary waste, efforts are needed to implement alternatives like exact pill dispensing.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Worldwide prevalence of chagas cardiomyopathy-an analysis from the global burden of disease dataset. 南美锥虫病心肌病的全球流行率--来自全球疾病负担数据集的分析。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-22 DOI: 10.1007/s15010-024-02408-5
Abdul Mannan Khan Minhas, Rachel Marcus, Salim S Virani, Michael D Shapiro, Robert J Mentz, Luis E Echeverria, Jonathan T Arcobello, Dmitry Abramov
{"title":"Worldwide prevalence of chagas cardiomyopathy-an analysis from the global burden of disease dataset.","authors":"Abdul Mannan Khan Minhas, Rachel Marcus, Salim S Virani, Michael D Shapiro, Robert J Mentz, Luis E Echeverria, Jonathan T Arcobello, Dmitry Abramov","doi":"10.1007/s15010-024-02408-5","DOIUrl":"https://doi.org/10.1007/s15010-024-02408-5","url":null,"abstract":"<p><strong>Purpose: </strong>The worldwide prevalence of Chagas Cardiomyopathy (CCM) as well as the trends in the prevalence of CCM over time have not been well characterized.</p><p><strong>Methods: </strong>An analysis of the Global Burden of Disease (GBD) data from 1990 to 2019 was conducted to assess the burden of CCM. This study focused on determining the prevalence of CCM, along with its age-standardized prevalence rate (ASR) per 1,00,000 people, considering various patient demographics and geographical regions as defined in the GBD. Additionally, the study examined the temporal trends over this 30-year period by calculating the estimated annual percentage change (EAPC) in CCM prevalence for the global population and specific subgroups.</p><p><strong>Results: </strong>Worldwide, the GBD reported 220,166 individuals with CCM in 1990 and 2,83,236 individuals in 2019, with a decline in the ASR from 5.23 (3.34-7.47) to 3.42 (2.2-4.91) per 1,00,000 individuals during that period. In 2019, the prevalence was highest in individuals over age 70 and in males compared to females. Among available geographic classifications in 2019, Latin American regions had the highest rates (ASR of 39.49-61.15/1,00,000), while high income North American and Western European regions had the lowest rates (ASRs of 0.67 and 0.34/1,00,000, respectively). Between 1990 and 2019, the worldwide prevalence of CCM per 1,00,000 decreased (EAPC of -0.35, -0.37 to -0.32), with similar trends among most regions and subgroups.</p><p><strong>Conclusion: </strong>This analysis of the GBD data reveals both global and country-specific patterns in the prevalence and trends of CCM. Notably, CCM shows the highest prevalence in Latin American countries, although it's also significantly present in regions beyond Latin America. Notably, the global age-standardized rate of CCM is on the decline, suggesting improvements in healthcare strategies or lifestyle changes across the world.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142499645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Results of a monocentric field study: value of histology compared to sonication method and conventional tissue culture in the diagnosis of periprosthetic joint infection (PJI). 更正:单中心现场研究结果:组织学与超声法和传统组织培养法在假体周围关节感染(PJI)诊断中的价值比较。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-21 DOI: 10.1007/s15010-024-02399-3
Alexander Röhrl, Frank Klawonn, Bernd Füchtmeier, Christian Wulbrand, Andre Gessner, Jozef Zustin, Andreas Ambrosch
{"title":"Correction: Results of a monocentric field study: value of histology compared to sonication method and conventional tissue culture in the diagnosis of periprosthetic joint infection (PJI).","authors":"Alexander Röhrl, Frank Klawonn, Bernd Füchtmeier, Christian Wulbrand, Andre Gessner, Jozef Zustin, Andreas Ambrosch","doi":"10.1007/s15010-024-02399-3","DOIUrl":"https://doi.org/10.1007/s15010-024-02399-3","url":null,"abstract":"","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID-19-pandemic changes and clinical characteristics of invasive group a streptococcal infections from 2015 to 2023. 2015年至2023年COVID-19大流行后侵袭性a组链球菌感染的变化和临床特征。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-17 DOI: 10.1007/s15010-024-02413-8
Markos K Tomidis Chatzimanouil, Susann Rößler, Dennis Nurjadi, Isidoros Iakovidis, Reinhard Berner, Nicole Toepfner, The Dresden G A S Study Group Stefan Richard Bornstein, Roland Aschoff, Martin Bornhäuser, Andreas Güldner, Florian Gunzer, Johannes Herold, Jurek Schultz, Pauline Wimberger, Thomas Zahnert
{"title":"Post-COVID-19-pandemic changes and clinical characteristics of invasive group a streptococcal infections from 2015 to 2023.","authors":"Markos K Tomidis Chatzimanouil, Susann Rößler, Dennis Nurjadi, Isidoros Iakovidis, Reinhard Berner, Nicole Toepfner, The Dresden G A S Study Group Stefan Richard Bornstein, Roland Aschoff, Martin Bornhäuser, Andreas Güldner, Florian Gunzer, Johannes Herold, Jurek Schultz, Pauline Wimberger, Thomas Zahnert","doi":"10.1007/s15010-024-02413-8","DOIUrl":"https://doi.org/10.1007/s15010-024-02413-8","url":null,"abstract":"<p><strong>Purpose: </strong>Since winter 2022, invasive GAS (iGAS) infections have re-emerged in Europe, causing severe diseases in children and adults. We aimed to examine whether this reported post-pandemic increase was associated with an increased disease severity and/or a shift in clinical disease phenotypes.</p><p><strong>Methods: </strong>We performed detailed clinical phenotyping of patients hospitalized with iGAS infections at a 1410-bed tertiary German Medical Center from 01/2015 to 09/2023.</p><p><strong>Results: </strong>One hundred seventy-eight patients were included: 50 children (28.1%) and 128 adults (71.9%). IGAS infections of Q1/2023 exceeded the pre-pandemic average by 551% (1200% for children). The mean age of affected patients shifted significantly post-pandemically (49.5 ± 26.5 to 32.4 ± 28.2 years of age, p < 0.05), mainly due to the higher percentage of children affected with iGAS infections (15.2% pre-pandemic, 44.2% post-pandemic). CFR was significantly lower for children (2%) compared to adults (11.7%) (p < 0.05) and decreased from 13% to 6.5% post-pandemically (p = 0.148). Duration of antibiotic therapy (13.5 (10 to 21) to 10 (9 to 14) days), length of hospital (10 (4 to 25) to 7 (5 to 15) days), and ICU stay (7.0 (2.5 to 18.0) to 5.0 (3.0 to 8.5) days) were shorter post-pandemically. Despite the higher post-pandemic percentage of affected children, PICU admissions (57% before to 32% after), use of catecholamines (28.6% to 11.8%), invasive ventilation (35.7% to 17.6%) and CFR (7% to 0%) were all lower after the pandemic.</p><p><strong>Conclusion: </strong>Children were at higher risk for iGAS infections post-pandemically. The surge of post-pandemic iGAS infections was not accompanied by increased iGAS-associated morbidity and mortality.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance. 有针对性的新一代测序--诊断结核分枝杆菌和耐药性的有效方法。
IF 5.4 2区 医学
Infection Pub Date : 2024-10-17 DOI: 10.1007/s15010-024-02411-w
Xiaocui Wu, Guangkun Tan, Chunlei Sun, Yang Wang, Jinghui Yang, Chunqiu Wu, Chaohui Hu, Fangyou Yu
{"title":"Targeted next-generation sequencing - a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance.","authors":"Xiaocui Wu, Guangkun Tan, Chunlei Sun, Yang Wang, Jinghui Yang, Chunqiu Wu, Chaohui Hu, Fangyou Yu","doi":"10.1007/s15010-024-02411-w","DOIUrl":"https://doi.org/10.1007/s15010-024-02411-w","url":null,"abstract":"<p><p>Targeted next-generation sequencing (tNGS) offers a high-throughput, culture-independent approach that delivers a comprehensive resistance profile in a significantly shorter turn-around time, making it promising in enhancing tuberculosis (TB) diagnosis and informing treatment decisions. This study aims to evaluate the performance of tNGS in the TB diagnosis and drug resistance detection of Mycobacterium tuberculosis (MTB) using MTB clinical isolates and bronchoalveolar lavage fluid (BALF) samples. A total of 143 MTB clinical isolates were assessed, tNGS, phenotypic antimicrobial susceptibility testing (AST), and AST based on whole genome sequencing (WGS) exhibited high concordance rates, averaging 95.10% and 97.05%. Among 158 BALF samples, culture, Xpert MTB/RIF, and tNGS reported 29, 70 and 111 positives, respectively. In the confirmed cases with etiological evidence (smears, cultures, or molecular test), the positive rate of tNGS (73/83, 87.95%) was higher than that of Xpert MTB (67/83, 80.72%). Additionally, 45% (27/60) of clinically diagnosed cases (with imaging or immunological evidence) were positive for tNGS. Further validation on the discrepant results between tNGS and Xpert MTB/RIF with droplet digital PCR (ddPCR) yielded 35 positives, tNGS detected all, and Xpert MTB/RIF only identified 6 positives. In conclusion, tNGS demonstrates robust and rapid performance in the identification of MTB and its associated drug resistance, and can be directly applied to clinical samples, positioning it as a promising approach for laboratory testing of tuberculosis.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":null,"pages":null},"PeriodicalIF":5.4,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信